The lactoperoxidase system links anion transport to host defense in cystic fibrosis by Conner, Gregory E. et al.
The Lactoperoxidase System Links Anion Transport To Host
Defense in Cystic Fibrosis
Gregory E. Conner1,3, Corinne Wijkstrom-Frei1, Scott H. Randell2, Vania E. Fernandez1, and
Matthias Salathe1
1Division of Pulmonary and Critical Care Medicine, University of Miami School of Medicine, Miami, FL,
Division of Pediatric Pulmonary Medicine, 2Cystic Fibrosis/Pulmonary Research and Treatment Center, The
University of North Carolina, Chapel Hill, NC, and 3Department of Cell Biology and Anatomy, University
of Miami School of Medicine, 1600 N.W. 10th avenue, Miami FL 33136
Abstract
Chronic respiratory infections in cystic fibrosis result from CFTR channel mutations but how these
impair antibacterial defense is less clear. Airway host defense depends on lactoperoxidase (LPO)
that requires thiocyanate (SCN−) to function and epithelia use CFTR to concentrate SCN− at the
apical surface. To test whether CFTR mutations result in impaired LPO-mediated host defense, CF
epithelial SCN− transport was measured. CF epithelia had significantly lower transport rates, did not
accumulate SCN− in the apical compartment. The lower CF [SCN−] did not support LPO antibacterial
activity. Modeling of airway LPO activity suggested that reduced transport impairs LPO-mediated
defense and cannot be compensated by LPO or H2O2 upregulation.
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Cystic fibrosis (CF) is one of the most common genetic disorders among Caucasians. The
disease is characterized by recurrent respiratory infections caused primarily by Staphylococcus
aureus and Pseudomonas aeruginosa [1]. Lifelong respiratory infections result in progressive
loss of lung function and shortened life expectancy. Chronic infection implies failure of airway
host defenses against bacterial colonization. However, the exact defects in CF host defense
that are primarily responsible chronic infection in this disease remain unclear. The normal
airway barrier to infection is complex and multifactorial. One possible view is that mucus
delays growth of pathogens and attachment of bacteria and other particles to epithelia cells
until cilia mechanically clear them. The complex composition of mucus must provide the
proper viscoelastic properties to permit ciliary clearance but also must contain broad-spectrum
antibiotic activities in order to be effective.
CFTR, the gene product responsible for CF, contains an anion channel that has been extensively
characterized [2]. CFTR mutations result in loss of functional anion channel activity on the
apical cell surface, although, it is not fully understood how a loss of anion channel activity
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completely explains defective antibacterial defenses. Several hypotheses have been proposed
to relate these two phenomena and focus on: a) the effects of airway surface liquid (ASL)
dehydration that leads to impaired ciliary and cough clearance of mucus [3]; b) the effects of
elevated ASL salt concentration on the activity of antimicrobials in mucus [4–6]; or c) CFTR
mediated defective bacterial-epithelial interactions [for reviews, see 7,8–11].
Current views of CF pathogenesis may be limited by incomplete knowledge regarding the array
of mechanisms at work in airway defense. For example, the lactoperoxidase (LPO) system has
recently been shown to be present in airways, and to be important for airway antibacterial
activity and bacterial clearance in both humans and sheep [12,13]. The LPO system works to
preserve sterility of secretions [14],[15] in several species including human. Similar to
myeloperoxidase (MPO) and eosinophil peroxidase (EPO), LPO uses H2O2 to catalyze
oxidation of the anion SCN− to the antibiotic OSCN− [16] via an oxidized enzyme intermediate
called compound I (LPO-O).
H2O2 + LPO → LPO − O + H2O
LPO − O + SCN− → OSCN− + LPO
Both SCN− and H2O2 are required for LPO to function in the airway lumen. Normal human
airway epithelia transport SCN− from the basolateral to the apical surface and concentrate it
in airway secretions [17]. This transport utilizes the sodium/iodide symporter at the basolateral
surface to mediate uptake of SCN− or I− into the cells followed by release to the apical surface
that is regulated by CFTR [17]. Normal human airway epithelia also actively produce H2O2
at the apical surface using Duox and release it into the apical surface liquid [18]. This airway
H2O2 production is increased through stimulation of purinergic receptors [18] that also act to
increase mucus secretion [19,20] and ciliary beating [21–23] all through intracellular Ca2+
increases. Thus, a complete antibacterial LPO system is present in the airway lumen and can
be regulated in concert with other facets of the airway host defense.
Since the LPO system is effective against staphylococci [24], E. coli and pseudomonads [24–
26] and since SCN− is a requisite substrate for LPO, defects in SCN− transport and resulting
loss of LPO activity could contribute, at least partially, to the chronic respiratory infections
seen in CF patients. Although MPO was previously thought to primarily use chloride as a
substrate, it is now recognized that MPO also uses SCN− and that SCN− maybe the
physiological substrate for MPO [27]. In addition, hypochlorite (OCl−), the product of MPO
oxidation of chloride, reacts almost instantaneously with SCN− at physiological concentrations
[28] to give OSCN− suggesting that SCN− may have a central role not only in LPO antibacterial
activity but also MPO antibacterial activity.
The described experiments test the hypothesis that CF airway epithelia are defective in
SCN− transport to the airway surface and that this defect may be reflected by impaired or altered
peroxidase antibiotic activity in CF epithelial cell secretions.
Methods
Cell Culture and Thiocyanate Transport Experiments
Human airways were obtained following IRB approved protocols from CF patients at the time
of transplant or from organ donors whose lungs were not used for transplant. Epithelial cells
were isolated, grown and differentiated on either 6.5 mm or 24 mm collagen-coated T-clear
membranes (Costar #3450) at an air-liquid interface as previously described [29,30]. All
experiments comparing non-CF and CF cells were performed with cultures grown
simultaneously and matched in passage number, the number of cells plated, and days in culture.
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All cultures had a resistivity ≥ 300 Ω.cm. Prior to initiating experiments, surfaces of ALI
cultures were washed with PBS, returned to the air interface and incubated 18–24 h with 70
μM 14C-SCN− (50 μCi/mM) in the basolateral media. To start the experiments, apical surfaces
of the cultures were rapidly washed three times with Dulbecco's PBS (50 μL for 6.5mm filters
or 500 μL for 24 mm filters). Following the third wash, additional aliquots were placed on the
apical surface for sequential 2 min incubations at 37° in humidified 5% CO2. Basolateral media
were sampled after the last wash. 14C-SCN− in media and apical washes was determined by
liquid scintillation counting. All of the collected 14C-SCN− was soluble following 10% TCA
precipitation showing that radiolabel was not covalently attached to protein.
PKA stimulation was accomplished by adding 500 μM dibutyryl cAMP and 10 μM forskolin
to the PBS washes. To inhibit CFTR during PKA stimulation, glibenclamide (500 μM) was
added to washes containing dibutyryl cAMP and forskolin.
Assay of Antibacterial Activity
Antibacterial activity assays were performed essentially as described previously [12].
Pseudomonas aeruginosa (ATCC 27853) were grown in LB broth overnight, collected in the
stationary phase, diluted to 5 – 6 x 104 / ml in LB broth with 15% glycerol and stored at −80ºC.
At least 24h prior to the experiments, basolateral media of matched non-CF and CF ALI
cultures (except controls) were supplemented with 100 μM SCN−. The apical surfaces of the
cultures were washed with 0.25 ml PBS and washes were pooled and stored at −20ºC. SCN−
dependent antibiotic activity was assayed using 560 μl of apical culture washes, adjusted to
pH 5.7, and containing 2400–3600 P. aeruginosa. Since LPO was not secreted by the cells
under these culture conditions, washes were supplemented with 1.1 μg/ml LPO and 10−5 M
H2O2. Control experiments were performed in the absence of basolateral addition of SCN− or
using only PBS never added to the cultures and adjusted to pH 5.7. Growth of bacteria was not
affected by addition of 1.125 μg/ml LPO, 10−5 M H2O2, or 5 x 10−4 M SCN− singly or in pairs.
However, addition of all three reconstituted a functional LPO system that was bactericidal. To
show SCN− dependence, apical CF culture washes were also supplemented to 5 x 10−4 M
SCN− in some experiments. Mixtures were sampled immediately and 4 h after incubation at
room temperature and CFU were determined by plating on LB Agar. Antibacterial activity was
expressed as a ratio of CFU after 4 h to the starting CFU in the sample to control for slight
differences in the starting number of bacteria.
Computational Modeling of LPO Activity
Differential equations describing LPO enzymatic activity were reiteratively integrated over
0.1 sec intervals using IgorPro (WaveMetrics, Portland, OR). Kinetic constants (k1 and k4)
were those published for human salivary lactoperoxidase [31] at pH 6.8 with the normal steady
state assumptions. Initial values for reactants, products and LPO are shown in table 1. The used
equations were:
dH2O2/dt = − k1 ∗ H2O2 ∗ LPO + k2 (1)
dLPO/dt = − k1 ∗ H2O2 ∗ LPO − k4 ∗ LPO − O ∗ SCN (2)
dLPO − O/dt = k1 ∗ H2O2 ∗ LPO − k4 ∗ LPO − O ∗ SCN (3)
dSCN/dt = − k4 ∗ LPO − O ∗ SCN + k3 (4)
dOSCN/dt = k4 ∗ LPO − O ∗ SCN (5)
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where k2 and k3 are the H2O2 production rate and SCN− transport rates respectively. The Igor
Pro procedure code is available on request to the authors.
Results
Thiocyanate Transport
We have previously shown that normal human bronchial epithelial cells actively transport
SCN− from the basolateral to apical surfaces and that the transport was regulated by CFTR as
it was stimulated by cAMP analogs and by forskolin, and inhibited by apical glibenclamide,
diphenylamine-2-carboxylic acid and 5-nitro-2- (3-phenylpropylamino)-benzoate [17]. Since
a loss of SCN− in the airway lumen might result in a loss of LPO antibacterial activity and
perhaps also affect neutrophil MPO antibacterial activity, we assessed whether SCN− transport
was defective in CF bronchial epithelial cells compared to normal epithelia. Airway epithelial
cells, obtained from CF lungs or non-CF lungs at the time of transplant or organ donation, were
passaged twice (thereby de-differentiated) and then cultured at an air-liquid interface (ALI)
for re-differentiation [29,30]. As expected CF cell cultures showed no change in short circuit
current in Ussing chambers following stimulation with forskolin
To measure the transport of SCN− across the epithelium, 14C-SCN− was added to the
basolateral media and, after overnight incubation to allow an approach to steady state, its rate
of appearance in the apical surface liquid was monitored. Airway epithelial cell cultures from
three separate CF patients were compared to non-CF control cultures from three individuals.
CF cells showed 4 fold reduced SCN− transport rates when compared to normal (CF, 2.3 ± 0.5
nmol/h/cm2 vs. non-CF, 9.3 ± 1.7 nmol/h/cm2; n=18; 3 donors, p < 0.0002, one way ANOVA)
(Fig. 1A). All three individuals had one ΔF508 allele, one had a second W1282X allele
(nonsense mutation), while the second alleles in the other two patients were unidentified
unknown. However, all were diagnosed with CF and underwent lung transplant. CFTR function
as diagnosed by an abnormal sweat test. Transport rates for cultures from each CF individual
were: ΔF508/W1282X, 1.69 ± 0.32 (n=8) and 2.41 ± 0.72 (n=5) as well as 3.65 ± 2.34 (n=3)
for the other two. The differences in SCN− transport between non-CF and CF cultures were
independent of the age of the cultures (repeated measurements from 2 – 8 week old cultures),
suggesting that a possible difference in time to reach full differentiation between CF and non-
CF cells was not responsible for these observations.
Exact determination of apical SCN− concentration was not possible in these experiments
because the small apical surface volumes naturally present on ALI cultures prevented accurate
sampling of CF cultures. However, comparison of the total amounts of SCN−, recovered in the
initial 0.5 ml PBS wash of the apical surface after overnight incubations with 14C-SCN− in the
basolateral media, showed 11-fold higher levels in non-CF compared to CF cultures (non-CF,
11.2 ± 3.0 nmol/cm2 vs. CF, 0.8 ± 0.2 nmol/cm2, n = 18, p < 0.0008, one way ANOVA; Fig.
1B). Even though CF cultures are reported to have about one half the amount of apical surface
fluid when compared to non-CF [3], the difference in accumulated apical 14C-SCN− between
CF and non-CF cultures would remain significant, even if this volume difference is taken into
account (5.5 fold). Thus, it appears that non-CF epithelial layers accumulate SCN− to
significantly higher levels than CF. On the occasions when apical surface liquid was visible
on non-CF cultures that had been pre-incubated with basolateral 14C-SCN−, direct sampling
(2–5 μl) allowed measurement of the [SCN−] and showed that it was concentrated 6 fold over
the 0.07 mM in the basolateral media to 0.43 ± 0.13 mM, n = 3. This concentration of SCN−,
measured in undiluted non-CF apical surface liquid, is close to levels measured in undiluted
airway secretions collected from patients, where we measured 0.5 mM [12]. Liquid was never
observed on the apical surface of CF cultures, as expected from a previous report [3] and
therefore, direct measurement of [SCN−] in CF apical surface fluid could not be made.
However, by estimating the values for CF cells using the difference to non-CF cells measured
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above (5.5 fold), the apical SCN− concentration appears likely to be close to that in the
basolateral media (0.4 mM divided by 5.5 would equal 0.072 mM).
Since previous studies showed that CFTR played a role in SCN− transport from the serosal to
mucosal compartments [17], we evaluated the possible contribution of CFTR anion channel
activity to the SCN− transport observed in cultures. Non-CF cultures showed the expected
increase in SCN− transport after stimulation of PKA by apical addition of dibutyryl cAMP (0.5
mM) and forskolin (10 μM), while CF cultures did not (Fig. 2, A–C). In non-CF airway
epithelia, both the PKA-stimulated and baseline SCN− transport are completely and reversibly
blocked by glibenclamide [17]. Previous studies showed that SCN− transport in normal airway
epithelia was also sensitive to diphenylamine-2-carboxylic acid and 5-nitro-2- (3-
phenylpropylamino)-benzoate but not affected by DIDS and DNDS [17]. Thus the lack of
cAMP stimulated SCN− transport by CF epithelia is consistent with the idea that SCN− is
delivered to the apical surface through CFTR.
Thiocyanate Transport Defects and In Vitro Antibacterial Activity
To assess the effects of reduced SCN− transport on LPO-mediated antibacterial activity, the
apical surfaces of cultures were washed with PBS and these washes were used in antibacterial
assays previously developed to assess LPO activity in human tracheal secretions [12]. The day
prior to washing, SCN− (100 μM) was added to the basolateral media of some cultures to allow
transport to the apical surface. Since culture conditions did not result in LPO synthesis and
secretion in these ALI cultures, washes were supplemented with exogenous bovine milk LPO
and H2O2 (10−5 M). Supplementing washes from cells cultured in the absence of basolateral
SCN−, with this concentration of H2O2 alone or in combination with LPO did not give rise to
any antibacterial activity (Fig. 3, compare panel A and B). However, incubation of P.
aeruginosa with LPO/H2O2 supplemented washes from non-CF cultures grown with
basolateral SCN− resulted in LPO-dependent killing of bacteria (Fig. 3, panel C). In contrast,
incubation of P. aeruginosa with LPO/H2O2 supplemented washes from CF cultures grown
with basolateral SCN− had no detectable LPO-dependent killing activity. Addition of
exogenous SCN− (0.5 mM) to LPO/H2O2 supplemented culture washes generated antibacterial
activity in CF samples grown with basolateral SCN−, demonstrating that the lack of
antibacterial activity was the result of defective SCN− transport by the CF epithelial cells (see
below). Addition of the same amount of SCN− to the non-CF culture washes grown with
basolateral SCN− increased the LPO-dependent activity, already present, due to the further
increase in [SCN−]. Thus, the lack of SCN− transport by CF cells, compromised an in vitro
LPO system reconstituted in apical washes of the ALI cultures [32]. Although small numbers
of bacteria were used in the assays, substrates were not replenished and were limiting.
Computational Modeling of LPO activity in Airway Surface Liquid (ASL)
Since LPO activity depends on adequate [SCN−], it is important to understand whether lower
LPO activity due to lower [SCN−], could be up-regulated by compensatory changes in enzyme
concentration or H2O2 production. To visualize the effects of decreased [SCN−] on LPO
enzyme activity, we estimated LPO activity as a function of [SCN−] by calculating reaction













As expected, the lower SCN− concentrations found in apical CF culture washes resulted in
lower enzymatic activity Fig 4A and B). Interestingly, LPO has increased activity with lower
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[SCN−] at lower pH that might be encountered during infection or with reduced bicarbonate
transport seen in CF (Fig. 4A and B). Increased initial LPO activity due to lower initial pH
resulted in more rapid depletion of SCN− and was not able to compensate for the loss of
SCN− transport (not shown).
To approximate the effects of lower SCN− transport, differential equations describing changes
in reactants were used to model LPO activity in ASL at pH 6.8. These computations allowed
assessment of the possible effects of increasing [LPO] and [H2O2] on LPO activity in an
otherwise normal airway except for a sharply reduced [SCN−] transport ass measured here in
CF airway epithelial cultures. The model used LPO kinetic constants at pH 6.8 [31], the
measured amounts of LPO in tracheal secretions [12], the measured rates of SCN− transport
by non-CF [17] and CF airway epithelia (above), as well as estimates of ASL volume [3] per
unit surface area. The concentration of H2O2 in ASL is not known. Therefore initial values of
[H2O2] were set to zero and H2O2 production rates were set to balance the transport of
SCN− and its consumption by LPO in normal airways. The CF model utilized an ASL volume
equal to half that of the normal model [3] to account for a possible increase in [SCN−] due to
a reduced volume. To account for equivalent synthesis and secretion of LPO to into this reduced
volume of ASL in CF, initial [LPO] was 2-fold normal in the reduced transport (CF) model.
The simulation was carried out for 600 sec. At 300 sec, LPO was increased 10 fold over the
initial concentration in both the CF and in the non-CF model to simulate possible compensatory
increases in enzyme concentration. Figure 5 shows the calculated concentrations of the
substrates and the rate. Figure 5A depicts [SCN−] changes in the normal and CF models. In
the low SCN− transport CF model, SCN− is rapidly consumed resulting in decreased rate of
product formation (Fig. 5C) and a corresponding increase in [H2O2] (Fig. 5B) as catalytic
consumption depletes SCN− faster than it is replenished by diminished transport and thus,
leading to decreased use of H2O2. To demonstrate that an increase of LPO could not offset the
loss of SCN− transport, [LPO] was increased at 300 sec, and only resulted in a short transient
increase in reaction velocity (Fig. 5C).
Similar upregulation of H2O2 production did not restore LPO activity in the CF model,
however, increased H2O2 production did stimulate LPO activity in the normal model until
[SCN−] fell due to inability of SCN− transport to sustain the increased catalysis (not shown).
Interestingly, increasing SCN− transport rate under normal conditions made little difference
in LPO activity as the enzyme is nearly saturated with substrate at normal transport rates.
Computation using LPO rate constants at pH 5.6 that could be encountered locally during
infection accelerated the loss of SCN− in the low transport CF model. Thus, this computational
model supports the idea that the reduced [SCN−] predicted by the above transport studies cannot
be compensated by upregulation of LPO or H2O2 or changes in pH. The model also predicted
that decreased SCN− transport may cause CF ASL to be deficient in SCN− rendering the LPO
system unable to generate OSCN−, therefore impairing the antibacterial properties of mucus
secretions.
Discussion
The experiments presented here showed that CF airway epithelia, cultured at the ALI, were
defective in transporting SCN− from the basolateral to the apical compartment. The absence
of PKA stimulated SCN− transport in CF cultures is consistent with a role for CFTR in
SCN− transport suggested by our previous studies [17]. The measured defect in SCN− transport
by CF ALI cultures was reflected in a reduction of SCN− accumulation on the apical surface
and this reduction resulted in a loss of reconstituted LPO antibacterial activity that relied on
substrate transported by the cultured epithelia. Finally, a computational model of LPO activity
supported the concept that the effect of the measured decrease in SCN− transport on LPO
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enzymatic activity could not be compensated by up-regulating either LPO or H2O2 and thus
predicted a loss of LPO-mediated host defense in CF airways. If the measured difference in
apical SCN− between CF and non-CF airway epithelial cells is reflected in vivo, it is likely to
be functionally significant since OSCN− production by LPO at the relevant SCN−
concentrations are significantly different [33] and bacterial growth in vitro is inversely
proportional to the [OSCN−] [34]. Although certain changes in CF epithelial phenotype in
culture have been noted by others, these changes were seen in primary cultures and disappeared
after 6–11 days in culture [35]. Our re-differentiated cultures (passaged once) have been in
culture for much longer and are not expected to exhibit these changes noted in primary cultures.
Exact determination of SCN− concentration in normal and CF airway secretions is not currently
possible. Thiocyanate content in normal secretions is near the limit of detection of colorimetric
assays [12] and dilutions associated with bronchoalveolar lavage will require development of
more sensitive methods. Our model predicted complete depletion of SCN− in CF secretions
and the presence of large amounts of MPO due to chronic infection of CF airways virtually
assures no SCN− to be measurable in secretions. Thus, accurate comparison of SCN− levels in
CF and normal airways will require development of a highly sensitive assay method and will
be best done in patients early in life prior to establishment of chronic infection and neutrophilic
inflammation.
In lieu of direct measurement of ASL [SCN−], the computational model presented here
predicted that decrease SCN− transport of the magnitude measured results in complete
depletion of this LPO substrate and that upregulation of LPO enzyme activity cannot
compensate for lower SCN− transport measured in the in vitro system. The model also
suggested that H2O2 normally produced by airway epithelia [18,36,37] and consumed by LPO
[38] will increase if SCN− transport is not able to provide sufficient substrate and might perhaps
lead to increased oxidative damage in the CF airway. Thus the model predicted that changes
in the LPO and H2O2 concentrations in CF ASL cannot offset the measured loss of SCN−
transport.
It is important to note that the computational model used empirically determined rate constants
for purified human LPO from saliva and thus the model does not take into account the presence
of other components normally found in normal and CF airways. The model therefore cannot
accurately predict the effects of other potential antibacterial peroxidase substrates such as
nitrite. Nor does the model take into account the formation of LPO compound II that can
generate SCN radicals and is now thought to be an important part of the normal peroxidase
catalytic cycle [39]. The model also does not address MPO activities and cannot predict a
complete loss of peroxidase mediated antibacterial activity but instead primarily serves to
predict that upregulation of LPO expression cannot compensate for the observed reduction in
SCN− transport.
Although most studies of MPO-mediated bacterial killing have concentrated on its use of
Cl−, SCN− has recently been shown to be the preferred substrate of MPO [27,40] and normally
OCl− immediately reacts with SCN− to produce OSCN− [28]. The presence of high levels of
MPO in CF airways, that also consumes SCN− [e.g. 27], virtually ensures the full consumption
of SCN− in the presence of an impaired transport system and suggests an increased use of
chloride as a substrate and generation of OCl−. Since OCl− is believed to very rapidly react
with SCN− in physiological conditions, increased production of OCl− that might also contribute
to increased oxidative damage in the airway. Although hypochlorite itself is a potent
antibacterial, CF airway secretions are reported to have high levels of taurine (> 3 mM) [41]
that reacts extremely rapidly with hypochlorite and thus is expected to buffer the antibacterial
effects [42,43]. Nevertheless mono and dichlorotaurine are also antibacterial, although much
less so than HOCl [44,45]. The mechanisms by with chlorotaurines are antibacterial are not
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known. Clearly, a full understanding of the effects of SCN− transport changes in CF airways
will require more investigation including studies of the phenotypic changes in bacteria that
occur after chronic colonization. Thus, impaired SCN− transport to the airway lumen could
potentially cause significant alteration of both the epithelial-derived LPO system as well as the
neutrophil-derived MPO antibacterial activity.
The SCN− permeability and conductance of the CFTR anion channel is known [e.g. 46,47,48]
and suggested that a SCN− transport deficiency might be relevant to increased infection in CF.
Our previous studies on SCN− transport by airway epithelia support a role for CFTR in
SCN− transport [17] and the decreased SCN− transport and lack of PKA stimulation in the CF
cultures shown here are also consistent with a role for CFTR. We have not ruled out the
possibility that NaI symporter in the basolateral membrane is also reduced in CF although such
a reduction is not expected to be relevant in the absence of functional CFTR.
Since LPO has antimicrobial activity against a broad spectrum of pathogens including
respiratory pathogens relevant in CF [e.g. 12], a CFTR dependent defect in LPO-mediated host
defense might be relevant to cystic fibrosis. In our studies shown here, and in previous studies
[12], small numbers of bacteria were used in an in vitro system that was not replenished with
either SCN− or H2O2 during the assay. In vivo, continuous production of H2O2 [18,36,49] and
SCN− transport in the presence of LPO are expected to continuously produce larger quantities
of OSCN− for antibacterial host defense that are expected to prevent colonization of the airway
but may not be able to eradicate an established infection.
There may be several reasons that the role of LPO in airway host defense, and a possible loss
of its activity due to the anion transport defect in CF, have not previously attracted attention.
First, studies that focus on antibacterial activity of airway secretions do not typically detect
LPO activity since LPO requires H2O2 as a substrate and H2O2 is rapidly consumed and not
present in secretions after collection and storage [38]. Thus, to detect LPO activity requires
replenishing secretions with the estimated low physiological [H2O2] something not generally
added in studies of antibacterial activity in airway secretions [e.g. 50]. These levels of H2O2,
added to in vitro peroxidase antibacterial systems, are well below the levels needed for killing
of bacteria by H2O2 alone [e.g. 12]. Second, broad screens of antibacterial substances have
often focused on components with molecular masses below that of LPO [e.g. 51]. Finally LPO
has an acidic pH optimum (~ pH 5.5) and shows reduced activity above pH 7.0. Thus, LPO’s
characteristics and substrate needs may have slowed appreciation of its role in airway host
defense.
Chronic infection in CF appears to arise from multiple defects in airway host defense. For
example, inadequate ASL leads to dehydrated mucus, reduced mucociliary clearance [3], and
decreased neutrophil migration into mucus [52]. Since LPO appears to be constitutively present
in normal airway secretions, loss of its activity due to a SCN− transport defect may be an
additional defect in CF airway host defense. Thus the data presented here support further studies
of SCN− levels in CF airways.
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Figure 1. Thiocyanate transport in CF airway epithelium is defective
Panel A. 14C-SCN− (70 μM) was added to the basolateral media of non-CF and CF cultures
for 18 – 24 h and stable unstimulated transport rates measured as described previously [17].
Non-CF cultures showed a 4-fold higher rate of transport using 18 from three non-CF and three
CF individuals (n= 18, p < 0.0001). Panel B. 14C-SCN− (70 μM) was added to the basolateral
media of cultures for 18 – 24 h. The 14C -SCN− accumulated on the apical surface was collected
in a PBS wash and measured by liquid scintillation counting (n = 18 cultures each from three
non-CF and three CF, p < 0.007).
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Figure 2. PKA stimulation increases thiocyanate transport in non-CF but not in CF airway epithelia
To initiate the experiments, apical surfaces of the cultures incubated overnight in 14C-SCN−
were rapidly washed three times. Additional PBS aliquots were placed on the apical surface
for sequential 2 min washes and 14C-SCN− was determined by liquid scintillation counting.
cAMP stimulation of SCN− efflux was demonstrated by adding dibutyryl cAMP and forskolin
to the PBS washes (18 min, indicated by the bar at top). The stimulated transport was inhibited
by addition of glibenclamide (28 min) to washes containing dibutyryl cAMP and forskolin.
SCN− flux is expressed in nMoles of SCN−/h normalized to 1 cm2 filter area. In the CF culture,
SCN− transport was greatly diminished and not stimulated by cAMP. Bars at the top of graphs
indicate the presence of PBS alone, dibutyryl cAMP and forskolin (PKAst), or dibutyryl cAMP,
forskolin and glibenclamide (Glib). Panels A–C show single experiments comparing pairs of
cultures obtained from three different CF patients and three different non-CF patients.
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Figure 3. Thiocyanate-mediated bacterial killing in ALI culture secretions
Non-CF (solid bars, n = 6 cultures on separate days) and CF (open bars, n = 4 cultures on
separate days) ALI cultures were incubated in the presence or absence of SCN− in the
basolateral media. Apical surfaces were washed with PBS and combined for assay of
antibacterial activity as described in Methods. Assays were performed with no additions (panel
A) or with LPO and H2O2 added to the washes (panel B). LPO and H2O2 did not increase the
antibacterial activity of the washes in the absence of SCN−, however in the presence of
basolateral SCN− (panel C), only non-CF culture washes showed antibacterial activity.
Addition of SCN− to washes of CF cultures restored the antibacterial activity and increased
the activity of non-CF culture washes (panel D).
Conner et al. Page 14













Figure 4. LPO activity varies with thiocyanate concentration and with pH
An arithmetic model of LPO activity using the kinetic constants published by Pruitt et al.
[31] calculated the expected LPO activity with [SCN−] between 0.0001 M and 0.01 M (left
panel) at pH 7.0, pH 6.5 and pH 6.0. The right panel shows an expanded view between 0 and
0.5 mM (0.4 mM being the concentration found in human airway secretions).
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Figure 5. Defective thiocyanate transport predicts a loss of LPO antibacterial activity
Computational modeling of LPO enzymatic activity in airway surface liquid shows predicted
changes in response to altered conditions in CF airways, i.e. decreased volume and decreased
SCN− transport rates. Initial conditions (shown in Table 1) were chosen based on published
values, except [H2O2] that was arbitrarily set to zero. The H2O2 production rate was set to
balance SCN− transport rates in normal cultures. Integration steps were 0.1 sec. Shown below
are values of non-CF (solid line) and CF (dotted line) conditions. Changes in [SCN−], (panel
A) and [H2O2], (panel B) include consumption by LPO catalysis and appearance due to
production or transport. Differentiation of OSCN− product concentration with respect to time
is shown in panel C. After 300 sec, LPO concentration was reset to a level 10 fold higher than
the CF initial [LPO] to mimic possible upregulation of the enzyme concentration in response
to lower SCN− transport. Despite a higher initial CF [LPO] to accommodate decreased CF
ASL volume, computation showed that SCN− could not be replaced fast enough given the
transport defect in CF. An increase in [LPO] (300 sec) was unable to restore LPO reaction rate
in CF due to faster consumption of SCN−. The model predicts a loss of antibacterial activity
in CF airways that cannot be compensated by increased LPO or H2O2.
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Table 1
Initial conditions for computations shown in Figure 5 were derived from estimates or measured amounts of
enzyme and substrates [12], transport rates (preliminary data, above), and volumes [3]. Transport rates described
in the text (shown in Figure 1) are recalculated to reflect the estimated ASL volume on 1 cm of epithelial surface.
CF LPO was increased 2 fold over normal to accommodate the reduced ASL volume in CF.
Normal CF units
[H2O2] 0 0 M
[SCN−] 4 x 10−4 1 x 10−4 M
[LPO] 7.2 x 10−8 14.4 x 10−8 M
SCN− Transport 1.04 x 10−6 0.263 x 10−6 M· sec−1
H2O2 production 1 x 10
−6 1 x 10−6 M· sec−1
ASL Volume (1 cm2) 2.5 x 10−6 1.25 x 10−6 1
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